Local control changes patterns of failure in prostate cancer patients
October 5th 2006A trimodality treatment regimen results in excellent local control that alters patterns of failure in patients with high-risk prostate cancer, according to a study published in the International Journal of Radiation Oncology, Biology & Physics (2006; 66:389-94).
Intensity-modulated radiation therapy offers long-term survival in PCa patients
October 5th 2006Prostate cancer patients receiving high-dose, intensity-modulated radiation therapy (IMRT) remained disease-free after an 8-year follow-up in a study conducted by researchers at Memorial Sloan-Kettering Cancer Center, New York.
Radical prostatectomy may be viable option for HIV-positive men
October 1st 2006New York-Radical prostatectomy may be considered as a safe and effective management option for prostate cancer in appropriately selected HIV-positive men, according to the experience of urologic surgeons at Memorial Sloan-Kettering Cancer Center, New York.
Radical prostatectomy may be viable option for HIV-positive men
October 1st 2006New York-Radical prostatectomy may be considered as a safe and effective management option for prostate cancer in appropriately selected HIV-positive men, according to the experience of urologic surgeons at Memorial Sloan-Kettering Cancer Center, New York.
CMS proposes cuts to urology procedures performed in ASCs
October 1st 2006Washington-On Aug. 8, 2006, the Centers for Medicare & Medicaid Services released a proposal to reform the Medicare ambulatory surgical center payment system beginning Jan. 1, 2008, and the news for urology appears to be mixed.
Don't let the 'doorknob' rob your productivity
October 1st 2006There isn't a urologist who hasn't experienced the following scenario: The doctor stands up to terminate the visit with the patient, asks the patient if there is anything else they would like to discuss, and the patient says no. The doctor closes the chart, puts his hand on the doorknob to leave the room, and the patient says, "There is one more thing I'd like to talk to you about."
CAPU targets Congress to improve prostheses funding
October 1st 2006Washington-Members of the Coalition for the Advancement of Prosthetic Urology (CAPU) spent several days during the last week of September pounding the halls on Capitol Hill, lobbying Congress to improve payment for prosthetic urology procedures and seeking comprehensive insurance coverage for prosthetic urologic procedures. Now they wait to see what their efforts may have won.
Treatments show early promise in older RCC patients
October 1st 2006Atlanta-Two studies presented here at the AUA annual meeting suggest that new treatments could be on the horizon for the treatment of elderly patients with renal cancer and comorbid conditions. The studies are small, follow-up was relatively short, and both investigators stated emphatically that the oncologic safety of these treatments must be studied further.
LPN shows small, significant effect on renal function
October 1st 2006Atlanta-Laparoscopic partial nephrectomy (LPN) for solitary and multiple renal tumors led to a small but statistically significant decrease in postoperative renal function, but the clinical significance of the finding remains unclear, according to a retrospective review of a patient series at the National Cancer Institute, Bethesda, MD.
Cystectomy outcomes: Does surgeon's age matter?
October 1st 2006Ann Arbor, MI-Surgeon age is not a significant predictor of risk of mortality after cystectomy, according to the results of a recently published study from researchers at the University of Michigan, Ann Arbor (Ann Surg 2006; 244:353-62).
Delaying cystectomy appears to raise mortality risk
October 1st 2006Atlanta-Delays of fewer than 25 days and more than 84 days from the time a general practitioner referral assigns a patient to cystectomy show a statistically significant, positive relationship to increased patient mortality. Results from a population-based study of the relationship between delayed treatment and mortality were presented at the AUA annual meeting here.
Highly toxic chemo may be effective in bladder TCC
October 1st 2006Atlanta-Neoadjuvant chemotherapy using a three-drug combination has demonstrated activity in locally advanced transitional cell carcinoma (TCC) of the bladder, but it also possesses considerable toxicity. That was the conclusion reported in a poster by University of Michigan researchers at the American Society of Clinical Oncology annual meeting.
Bilateral varicocelectomy improves odds of pregnancy
October 1st 2006Atlanta-Men whose infertility is due to varicocele may be able to improve the likelihood of achieving impregnation by undergoing bilateral, rather than unilateral varicocelectomy, when indicated. This was the conclusion of the authors of a Canadian study presented here at the AUA annual meeting.
Performing vasectomy reversal? Use a microscope
October 1st 2006Atlanta-If you're going to perform a vasectomy reversal, use a microscope. Despite the additional time and cost involved, microsurgical vasovasostomy is superior to the loupe-assisted macroscopic technique, findings from a recent study from Korea confirm.
Secondary treatment for prostate cancer shows wide regional variations
October 1st 2006Los Angeles-A study evaluating secondary care for men with prostate cancer provides useful information for patient counseling, but also underlines the existence of significant regional variations in treatment patterns, and so speaks to the need for a better evidence base on which to develop guidelines for high-quality care, said UCLA researchers.
Few low-risk prostate cancer patients undergo observation
October 1st 2006Ann Arbor, MI-Evidence-based expectant management of men with lower-risk prostate cancer does not seem to be catching on among physicians and their patients. A new study suggests that, among men who are appropriate candidates for the wait-and-see approach, physicians are treating more than half with surgery or radiation therapy.
Radical prostatectomy superior to other treatments for cT4 disease
October 1st 2006Atlanta-Patients who undergo radical prostatectomy for clinical stage T4 prostate cancer have a higher survival rate than do patients who receive radiation or hormone therapies alone, and surgical prostate cancer patients' survival is comparable to that of patients who receive both hormone and radiation therapies.